Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeiGene is a commercial-stage biotechnology company with global sales... Show more
ONC is expected to report earnings to fall 80.80% to 23 cents per share on August 22
Q2'25
Est.
$0.23
Q1'25
Beat
by $1.65
Q4'24
Missed
by $0.42
Q3'24
Beat
by $0.95
The last earnings report on May 07 showed earnings per share of $1.22, beating the estimate of -43 cents. With 424.80K shares outstanding, the current market capitalization sits at 29.59B.